Volume 21, Number 3—March 2015
Research
Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
Table 2
P1 type |
MLVA types (no. strains) |
Subtype 1, n = 51 |
1/4/5/7/2 (3), 2/3/6/6/2, 2/4/5/7/2 (2), 3/3/5/6/2 (2), 3/4/5/5/2 (2), 3/4/5/7/2 (5), 4/4/5/6/2 (2), 4/4/5/7/2 (11), 4/4/6/7/2, 5/3/5/6/2, 5/3/6/6/2, 5/4/5/7/2 (11), 6/3/5/7/2, 6/4/5/7/2 (3), 7/4/5/7/2 (3), 9/4/5/7/2 |
Subtype 2, n = 2 |
5/3/6/6/2 (2) |
Variant 2a, n = 19 |
2/3/5/6/2 (2), 3/3/5/6/2 (6), 4/3/5/6/2 (2), 5/3/5/6/2 (5), 6/3/5/6/2 (2), 6/4/5/6/2, 7/4/5/7/2 |
Variant 2b, n = 8 |
2/3/6/6/2 (4), 5/3/6/6/2 (2), 5/4/6/6/2, 6/3/5/6/2 |
Variant 2c, n = 7 | 3/3/5/6/2 (2), 4/3/5/6/2, 5/3/5/6/2 (3), 6/3/5/6/2 |
*Underlining indicates MLVA types that occur in both subtype 1 and subtype 2/variant 2 strains. MLVA, multilocus variable-number tandem-repeat analysis.
1Joint senior authors.
2Members of the CAPNETZ Study Group are listed at the end of this article.
Page created: February 18, 2015
Page updated: February 18, 2015
Page reviewed: February 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.